JPRN-UMIN000017744已完成未知
Allogeneic hematopoietic stem cell transplantation for elderly patients - Allo-HSCT for elderly patients
nivesity of Tokyo Hospital, Department of Hematology and Oncology0 个研究点目标入组 50 人开始时间: 2015年5月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 60years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Presence of other lethal complications. (2) Severe heart disease (ejection fraction < 40 %, uncontrollable arrhythmia or hypertension). (3) Severe kidney dysfunction (CCr < 30 ml/min). (4) Severe respiratory diease (PaO2 < 70 mmHg, DLCO < 50% or FEV1.0 < 60 %). (5) Severe liver dysfunction (T.Bil > 2.5 mg/dl, cirrhosis). (6) Cases considered to be not suitable in the conference of our department.
研究者
相似试验
已完成
不适用
Allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-haploidentical related donor using reduced dose of posttransplantation high-dose cyclophosphamide (PTCy) for poor prognosis or refractory hematological malignancies (OCU16-2)Acute myeloid leukemia(AML) Acute lymphoblastic leukemia(ALL) Acute leukemias of ambiguous lineage Myelodysplastic syndrome(MDS) Chronic myeloid leukemia(CML) Adult T-cell leukemia/lymphoma(ATLL) Malignant lymphoma(ML)JPRN-UMIN000026028Osaka City University33
招募中
2 期
Allogeneic hematopoietic stem cell transplantation from HLA6/8-4/8 matched related donor for poor prognostic or refractory hematologic malignancy and solid tumor - Ibaraki Children's Hospital phase II studyAcute leukemia, malignant lymphoma, and solid tumorJPRN-UMIN000027010Ibaraki Children's Hospital30
已完成
2 期
Allogeneic hematopoietic stem cell transplantation for aplastic anemia using low-dose anti-thymocyte globuliSAAJPRN-UMIN000006071Kanto Study Group for Cell Therapy28
进行中（未招募）
1 期
Stem cells transplant from matched donor in patients with chronic myeloid leukemia who do not improve with TKI therapyChronic Myeloid LeukemiaMedDRA version: 18.0Level: LLTClassification code 10054352Term: Chronic phase chronic myeloid leukemiaSystem Organ Class: 100000004864EUCTR2014-003126-40-ITIVERSITà DEGLI STUDI MILANO BICOCCA20
已完成
不适用
Allogeneic hematopoietic stem cell transpalntation using Thymoglobulin for patients with T-cell malignancyT-cell malignancyJPRN-UMIN000015736ational Cancer Center Hospital15